Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2007; 13(40): 5343-5350
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Figure 1 Cumulative recurrence rates after curative treatment of HCC.
A: Rates of first recurrence compared between IFN and non-IFN groups, showed no significant difference (P = 0.153); B: Rates of second recurrence compared between IFN and non-IFN groups. The second recurrence rate for the IFN group was lower than that for the non-IFN group (P = 0.022).
- Citation: Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J Gastroenterol 2007; 13(40): 5343-5350
- URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i40.5343